MindWalk Holdings
Austin, Texas, United States · Artificial Intelligence, Biotechnology, Healthcare
MindWalk is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT® technology and the LensAI™ platform, MindWalk unifies sequence, structure, function, and literature into a single computational language. The platform supports rapid epitope mapping, de novo molecular design, and population-scale biologics analytics.
Key facts
- Headquarters
- Austin, Texas, United States
- Employees
- 91
- Industries
- Artificial Intelligence, Biotechnology, Healthcare
- Status
- Public (HYFT)
- Website
- www.mindwalkai.com
Recent activity at MindWalk Holdings
MindWalk Holdings funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2018 | Pre-Seed | $8K |
Leadership
- Jennifer Bath, Executive Officer, Director
- Robert Burke, Director
- James Kuo, Director
- Guy Champagne, Director
- Robert Beecroft, Executive Officer, Director
- Greg Smith, Director
- Thomas Lynch, Chief Business Officer
- Thomas W. Lynch, Chief Business Officer
- NATASHA TSAI, Executive Officer
Verified email and direct lines for MindWalk Holdings’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
MindWalk Holdings in the news
- MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI - Business Wire (Jul 23, 2026)
- MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function - Yahoo Finance (Oct 06, 2026)
- MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026 - Yahoo Finance (Sep 08, 2026)
- Protein-shape prediction went live in minutes. MindWalk's antibody analysis ran ~5x faster. - Stock Titan (Sep 21, 2026)
- Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context - GlobeNewswire (Oct 06, 2026)
- MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery - Yahoo Finance (Jun 10, 2026)
- MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours - Business Wire (Oct 21, 2026)
- MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Yahoo Finance (Jun 12, 2026)
Companies similar to MindWalk Holdings
- Omniscient Neurotechnology · Artificial Intelligence, Biotechnology, Healthcare, Machine Learning
- Vektor Medical · Artificial Intelligence, Biotechnology, Healthcare, Machine Learning
- Corvex Legacy Holdings · Artificial Intelligence, Biotechnology, Healthcare, Machine Learning
- Rocket One · Artificial Intelligence, Biotechnology, Healthcare, Machine Learning
- Welldoc · Artificial Intelligence, Biotechnology, Healthcare, Machine Learning
About MindWalk Holdings: questions and answers
What does MindWalk Holdings do?
MindWalk is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT® technology and the LensAI™ platform, MindWalk unifies sequence, structure, function, and literature into a single computational language. The platform supports rapid epitope mapping, de novo molecular design, and population-scale biologics analytics.
Where is MindWalk Holdings headquartered?
MindWalk Holdings is headquartered in Austin, Texas, United States.
How many employees does MindWalk Holdings have?
MindWalk Holdings has about 91 employees.
Has MindWalk Holdings raised funding?
Yes. Fundz has recorded 1 funding event for MindWalk Holdings. The most recent, Pre-Seed of $8K, was in Jul 2018.
What is the latest news on MindWalk Holdings?
On Oct 22, 2026, MindWalk Holdings Corp. Announces Departure of Thomas Lynch as Chief Business Officer
Is MindWalk Holdings a public company?
Yes. MindWalk Holdings is publicly traded under the ticker HYFT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy